Middle meningeal artery embolization for chronic subdural hematoma
Part of Brain & nervous system, Heart & circulation, Injuries & trauma clinical trials.
This trial tests a minimally invasive procedure to treat chronic subdural hematoma (a slow bleed on the brain). It aims to stop the bleeding and reduce the risk of needing surgery.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 21 years or older.
- You live in Puerto Rico and speak English or Spanish.
- You have a chronic subdural hematoma seen on a brain scan (CT or MRI).
- You have not had prior surgery or another procedure for this condition.
- You have not had a stroke or major disability before this condition.
- You are not pregnant and have no serious kidney problems or other conditions that would make the procedure unsafe.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies a procedure called middle-meningeal-artery embolization, which blocks the blood supply to a chronic subdural hematoma (a slow-growing blood collection around the brain). It compares outcomes in people with one-sided versus both-sided bleeds, and aims to see if this less invasive treatment can help reduce the need for surgery or improve recovery.
This trial tests a procedure called middle meningeal artery embolization, which aims to stop the bleeding and reduce the fluid buildup from a chronic subdural hematoma. It may be an option for patients who have a hematoma at least 10mm thick and one or more risk factors such as older age, blood thinners, diabetes, or certain scan features.
This trial compares a newer, less invasive treatment (embolization) with traditional surgery to treat chronic subdural hematoma (a slow bleed on the brain). It aims to see which approach works better and has fewer side effects.
This study looks at a procedure called middle meningeal artery embolization, which blocks blood flow to the lining of the brain to help treat a chronic subdural hematoma (a slow bleed on the brain surface). The goal is to see how well this procedure works for adults.
This trial tests adding a drug called bevacizumab (given directly into the blood vessels of the brain) to the standard procedure of middle meningeal artery embolization for a chronic subdural hematoma (a slow blood clot on the brain). The goal is to see if the combination helps reduce the chance of the clot returning.
This trial studies whether an add-on, minimally invasive procedure works better than standard care for a specific brain blood-vessel problem (CSH) that is larger than 10 mm. It may help reduce symptoms or prevent worsening, if you meet the size and location requirements.
Hear when a new Chronic Subdural Hematoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.